About: A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 February 1994

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 1994 (uk) article scientifique publié en 1994 (fr) im Februar 1994 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en febreru de 1994 (ast) artikull shkencor i botuar më 01 shkurt 1994 (sq) scientific article published on 01 February 1994 (en)
publication date	wds:Q57222829-DBA06C5E-69A9-4474-81A0-68E6CA31661B
publication date	1994-02-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57222829-B8087362-4A25-4127-AB67-564BF00467AE
language of work or name	English
exact match	wds:Q57222829-DCC6966C-6176-4935-B83D-0FD1B6B5DC71
exact match	https://scigraph.springernature.com/pub.10.1007/bf02245440
cites work	wds:Q57222829-033A12F0-A15D-4B79-AD0C-CE17A873576B wds:Q57222829-03BD4B79-75F9-4392-85B6-AFDCE251E440 wds:Q57222829-07208151-2F92-49E6-B431-0C1BEDAC5784 wds:Q57222829-119F2856-30C8-4658-B877-4ADE67DFBD41 wds:Q57222829-1B257831-0D3B-4175-876D-CABC87A7A6D6 wds:Q57222829-261FF0AE-4329-4DD2-B5B5-585B24307CC4 wds:Q57222829-290E2D30-5980-43D4-8A9B-03F0C5FE9CB7 wds:Q57222829-545D8FBA-FB90-4992-959E-DD6C522391B8 wds:Q57222829-851B5556-9CD2-4BA8-9B12-C7C503FB835D wds:Q57222829-8E474B44-F262-4B11-9AFB-7EE17C9BC777 wds:Q57222829-9E0250B1-B822-4091-BBF3-2685640202D2 wds:Q57222829-9FD8E8CF-FE21-4A21-A1E1-288BC586F24F wds:Q57222829-A10FF3BA-7995-421E-9A61-EDC63E098EFE wds:Q57222829-A88C391C-6B03-4D22-A53A-B2AE6849F2CC wds:Q57222829-B1A6AA46-CD8D-4B78-A121-E51D4F2EE8A7 wds:Q57222829-BA3C1DE8-D431-424B-9257-6C34A43522C8 wds:Q57222829-C20B4A97-F0CC-4519-9331-58EBFB189838 wds:Q57222829-C81EB7CC-7D95-460B-AD1E-4E47858CABA6 wds:Q57222829-C95E5FCF-A04B-4EC1-9F53-6EBD98E85D9D wds:Q57222829-D6336D45-5FF7-4515-8EEF-8F5F1CBD2F96
cites work	Perphenazine decanoate and cis(z)-flupentixol decanoate in maintenance treatment of schizophrenic outpatients. Serum levels at the minimum effective dose The relationship between perphenazine plasma levels and clinical response in acute schizophrenia Long-term depot neuroleptic treatment with perphenazine decanoate. I. Efficacy and side effects in a 12 month study of 42 drug monitored psychotic patients The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients Zuclopenthixol decanoate and haloperidol decanoate in chronic schizophrenia: a double-blind multicentre study Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. I. A one year double-blind study of clopenthixol decanoate and flupenthixol palmitate Haloperidol blood levels and clinical effects A gas chromatographic method for determining haloperidol. A sensitive procedure for studying serum concentration and pharmacokinetics of haloperidol in patients Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placebo Comparison of quality of life with standard of living in schizophrenic out-patients Plasma level monitoring of antipsychotic drugs. Clinical utility A depot neuroleptic withdrawal study. Plasma concentration of fluphenazine and flupenthixol and relapse frequency Pharmacokinetics of haloperidol decanoate. A 2-year follow-up Quality of life perspectives in long-term care: staff and patient perceptions Prolactin and neuroleptic drugs Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response Haloperidol decanoate in chronic schizophrenia: a study of 12 months with plasma levels A multicenter multidimensional study of some new longacting neuroleptic drugs
author name string	wds:Q57222829-3F8FE09E-DADD-4F5E-8841-A00475DF8DAE wds:Q57222829-5EA0C58A-7031-49FB-B8F0-BD75E3150C5B wds:Q57222829-800457A8-FFE2-4A27-9FB4-6D8B127EACA6 wds:Q57222829-88087497-BB13-405E-86DC-9A06EF5AABFF wds:Q57222829-97943985-68C2-43E7-9A11-40AB7FFFD02B wds:Q57222829-D993058E-814B-488C-A265-8FF72DBFF4A4 wds:Q57222829-E6ADB4F1-B2D1-43C8-A417-95DA62C75A3E wds:Q57222829-F933A93F-733B-4750-BD9F-9824DCB763F8 wds:Q57222829-FE1B0B14-99CB-48D6-B038-A701D9CDDA3A
author name string	R Persson E Mårtensson G Nyberg G Roman I Giös K O Svärd O Stockman S J Dencker T Nordén
rdfs:label	A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients (en) A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients (nl) A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients (sq)
skos:prefLabel	A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients (en) A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients (nl) A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients (sq)
name	A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients (en) A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients (nl) A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients (sq)
title	wds:Q57222829-413CB9D1-807C-42C3-A4EB-527688870FE3
title	A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients (en)
page(s)	wds:Q57222829-211CA72B-5AC6-4ABD-81EE-3FEC828E8622
page(s)	24-30
instance of	wds:Q57222829-533D47CA-318F-423A-9070-6784B7B43B4A
instance of	scholarly article
main subject	wds:Q57222829-B9DE14F6-984A-410B-B323-7C27F3871D36 wds:Q57222829-D059F219-2E72-4D34-82A0-EFDDCC418F97
main subject	haloperidol schizophrenia
PubMed ID	wds:Q57222829-F2C7EA68-0A64-434D-84CF-8B2C95F75A1F
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7846204
PubMed ID	7846204
published in	wds:Q57222829-72FFA460-E570-4B0C-9FB1-53F60144DE97
published in	Psychopharmacology
issue	wds:Q57222829-CE15D0FE-58CB-41C5-A500-32E1F33A100C
volume	wds:Q57222829-B889DE99-E5B6-4535-888E-CA7133A930CA
issue	1
volume	114

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software